Henry Schein Inc., a healthcare products B-to-B marketer, has been authorized by its board to buy back up to $100 million of its outstanding common stock.
Advertisement
Henry Schein Inc., a healthcare products B-to-B marketer, has been authorized by its board to buy back up to $100 million of its outstanding common stock. When this is added to a current stock buyback program, the company may repurchase a total of nearly $120 million in stock.
The Melville, NY-based company currently has 87 million shares outstanding, and the newly announced program represents roughly 3% of the company’s stock. The shares have been trading at around $40 each, and on Tuesday closed at $40.15.
